Obermatt

Green Thumb Industries

CNX:GTII · CA39342L1085
PharmaceuticalsLarge

360

79
EV / EBIT48
Price / Owner Earnings53
Owner Earnings Yield88
Dividend Yield1
Price/Sales68
EV / Gross Profit75
Price/Book62
Return on Capital47
Cash Return on Capital73
Return on Equity54
EBIT Margin46
Gross Profitability43
Cash Conversion79
Accruals59
Owner Earnings Margin67
Sales growth31
Profit Growth52
Long-Term EPS Growth23
Owner Earnings Growth89
Reinvestment37
Price momentum54
Debt load55
Refinancing72
Debt Payback53
Liquidity85
Analyst ratings100
Opinion Changes90
Price Target Upside80
Market mood53
Value Creation16/20strong value creator
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Green Thumb Industries generates returns well above its cost of capital, the foundation of durable shareholder value.

Profile

CountryUSA
IndustryPharmaceuticals
SizeLarge
TypePublic Company
ExchangeCNSX
Employees1,687
ISINCA39342L1085
Last UpdateApr 2, 2026
Themes
CannabisAlternative Medicine

Description

Green Thumb Industries Inc. (Green Thumb) operates as a national cannabis consumer packaged goods company. Green Thumb manufactures and distributes a portfolio of cannabis consumer packaged goods brands, including &Shine, Beboe, Dogwalkers, Doctor S…

Analysis

Middle-of-the-road

Green Thumb Industries Inc. sits in the middle of our grid: average quality, average price, no obvious signal in either direction.

On valuation, the picture is attractive. The owner-earnings multiple stands at 8.9×; owner earnings: the cash an owner could take out each year.

Growth is moderate; the safety picture is sturdy. The company scores 16/20 on our value-creation score: strong value creator.

No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.

360° rank · history

1007550250
86
2023202420252026

All-time high

86

Jun 2026

All-time low

48

Jan 2024

Average rank

68

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
68
70
47
30
Price/Earnings
1
30
10
22
Price/Book
62
72
47
28
Dividend Yield
1
1
1
1
Value (overall)
31
55
15
5

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Green Thumb Industries with its peers
Tilray Brands
NSQ:TLRY
18
CountryCanada
IndustryPharmaceuticals
SizeMedium
Full Stock Analysis →
High Tide
CVE:HITI
62
CountryCanada
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Cresco Labs
CNX:CL
43
CountryUSA
IndustryPharmaceuticals
SizeMedium
Full Stock Analysis →
Johnson & Johnson
NYQ:JNJ
64
CountryUSA
IndustryPharmaceuticals
SizeMedium
Full Stock Analysis →
SNDL
NAQ:SNDL
45
CountryCanada
IndustryPharmaceuticals
SizeMedium
Full Stock Analysis →
Cronos Group
TOR:CRON
45
CountryCanada
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →